Cargando…
Investigational Agents for the Treatment of Resistant Yeasts and Molds
PURPOSE OF REVIEW: This review summarizes the investigational antifungals in clinical development with the potential to address rising drug resistance patterns. The relevant pharmacodynamics, spectrum of activity, preclinical studies, and latest clinical trial data are described. RECENT FINDINGS: Ag...
Autores principales: | Seiler, Garret T., Ostrosky-Zeichner, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162489/ https://www.ncbi.nlm.nih.gov/pubmed/34075318 http://dx.doi.org/10.1007/s12281-021-00419-5 |
Ejemplares similares
-
Role of Serological Tests in the Diagnosis of Mold Infections
por: Richardson, Malcolm, et al.
Publicado: (2018) -
The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach
por: Maghrabi, Firas, et al.
Publicado: (2017) -
Yeasts as Biopharmaceutical Production Platforms
por: Kulagina, Natalja, et al.
Publicado: (2021) -
RIPK3 Facilitates Host Resistance to Oral Toxoplasma gondii Infection
por: Cervantes, Patrick W., et al.
Publicado: (2021) -
Eicosanoid production by Candida parapsilosis and other pathogenic yeasts
por: Chakraborty, Tanmoy, et al.
Publicado: (2019)